This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting specific diseases, particularly those requiring enantiomerically pure substances. Its structure, featuring a trifluorophenyl group, makes it valuable in the design of molecules with enhanced binding affinity and metabolic stability. It is often employed in research and development processes to create potential therapies for conditions such as diabetes, cardiovascular diseases, and neurological disorders. Additionally, its hydrochloride form improves solubility, facilitating easier handling and formulation in drug manufacturing.